Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Per, Lindahl"'
Autor:
Zhiyuan V. Zou, Kristell Le Gal, Ahmed E. El Zowalaty, Lara E. Pehlivanoglu, Viktor Garellick, Nadia Gul, Mohamed X. Ibrahim, Per-Olof Bergh, Marcus Henricsson, Clotilde Wiel, Levent M. Akyürek, Martin O. Bergo, Volkan I. Sayin, Per Lindahl
Publikováno v:
Antioxidants, Vol 10, Iss 2, p 241 (2021)
Dietary antioxidants and supplements are widely used to protect against cancer, even though it is now clear that antioxidants can promote tumor progression by helping cancer cells to overcome barriers of oxidative stress. Although recent studies have
Externí odkaz:
https://doaj.org/article/080aefb9e0cd473fb29d3da2d5029ec5
Autor:
Mohamed X. Ibrahim, Anna Staffas, Volkan I. Sayin, Per Lindahl, Christin Karlsson, Murali K. Akula, Martin O. Bergo, Jaroslaw Cisowski
Publikováno v:
Leukemia. 35:606-609
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da3302463463b6588d6a8250e3691425
https://doi.org/10.1038/s41375-020-0859-0
https://doi.org/10.1038/s41375-020-0859-0
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0166918 (2016)
Vascularization of atherosclerotic plaques has been linked to plaque vulnerability. The aim of this study was to test if the vascularization was increased in upstream regions of early atherosclerotic carotid plaques and also to test if the same patte
Externí odkaz:
https://doaj.org/article/21ee7c5c20fd40ac9b67b9fb29e1cab1
Autor:
Per Lindahl, Martin O. Bergo, Zhiyuan V. Zou, Lara E. Pehlivanoglu, Clotilde Wiel, Levent M. Akyürek, Volkan I. Sayin, Mohamed X. Ibrahim, Per-Olof Bergh, Marcus Henricsson, Nadia Gul, Ahmed E. El Zowalaty, Kristell Le Gal, Viktor Garellick
Publikováno v:
Antioxidants, Vol 10, Iss 241, p 241 (2021)
Antioxidants
Volume 10
Issue 2
Antioxidants
Volume 10
Issue 2
Dietary antioxidants and supplements are widely used to protect against cancer, even though it is now clear that antioxidants can promote tumor progression by helping cancer cells to overcome barriers of oxidative stress. Although recent studies have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5b003ca8521e259b24b065f477ddf1b
https://www.mdpi.com/2076-3921/10/2/241
https://www.mdpi.com/2076-3921/10/2/241
Autor:
Erik Larsson, Björn Wahlstrand, Bo Hedblad, Thomas Hedner, Sverre E Kjeldsen, Olle Melander, Per Lindahl
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e62035 (2013)
Genome-wide association (GWA) studies usually detect common genetic variants with low-to-medium effect sizes. Many contributing variants are not revealed, since they fail to reach significance after strong correction for multiple comparisons. The WTC
Externí odkaz:
https://doaj.org/article/ceaec8c178584ba08f48f3f8de8a8f7e
Autor:
Anna Nilton, Volkan I Sayin, Anna Staffas, Erik Larsson, Julia Rolf, Marleen M Petit, Lars Palmqvist, Birgitta Swolin, Susanna Cardell, Per Lindahl
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e70022 (2013)
Hematopoiesis is regulated by transcription factors that induce cell fate and differentiation in hematopoietic stem cells into fully differentiated hematopoietic cell types. The transcription factor zinc finger protein 148 (Zfp148) interacts with the
Externí odkaz:
https://doaj.org/article/5af5c80eb672437ea69eff62b01c5cb3
Autor:
Volkan I Sayin, Anna Nilton, Mohamed X Ibrahim, Pia Ågren, Erik Larsson, Marleen M Petit, Lillemor Mattsson Hultén, Marcus Ståhlman, Bengt R Johansson, Martin O Bergo, Per Lindahl
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e55720 (2013)
The transcription factor Zfp148 (Zbp-89, BFCOL, BERF1, htβ) interacts physically with the tumor suppressor p53 and is implicated in cell cycle control, but the physiological role of Zfp148 remains unknown. Here we show that Zfp148 deficiency leads t
Externí odkaz:
https://doaj.org/article/93f7a0c3f0cf4aa9948ba42e4716e5d7
Autor:
Christin, Karlsson, Murali K, Akula, Anna, Staffas, Jaroslaw, Cisowski, Volkan I, Sayin, Mohamed X, Ibrahim, Per, Lindahl, Martin O, Bergo
Publikováno v:
Leukemia. 35(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::556f041b436e832504951b269a2148ba
https://pubmed.ncbi.nlm.nih.gov/32398789
https://pubmed.ncbi.nlm.nih.gov/32398789
Autor:
Ella M. Eklund, Jozefina J. Dzanan, Markus Lindberg, Anna Staffas, Ben O. Titmuss, Angana A. H. Patel, Erik Larsson, Per Lindahl, Zhiyuan V. Zou, Eva Forssell-Aronsson, Kristell Le Gal, Inger Johansson, Nadia Gul, Åsa Tivesten, Abdulmalik A. Bokhari, Volkan I. Sayin, Viktor Garellick, Martin O. Bergo
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Recent data suggest that the transcription factor Zfp148 represses activation of the tumor suppressor p53 in mice and that therapeutic targeting of the human orthologue ZNF148 could activate the p53 pathway without causing detrimental side effects. W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2517015738dd4c30c2e85ab566ec96a3
https://pubmed.ncbi.nlm.nih.gov/32843651
https://pubmed.ncbi.nlm.nih.gov/32843651
Autor:
Nadia Gul, Carolina Tängemo, Chandu Ala, Martin O. Bergo, Rosie Perkins, Sanna Linsefors, Per Lindahl, Samuel Tuyizere, Erik Larsson, Joakim Karlsson, Zhiyuan Zou
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-12 (2019)
The mut-T homolog-1 (MTH1) inhibitor TH588 has shown promise in preclinical cancer studies but its targeting specificity has been questioned. Alternative mechanisms for the anti-cancer effects of TH588 have been suggested but the question remains unr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3080c8b3ca6b016a7a5e14a7eacd2bcb
https://doi.org/10.1038/s41598-019-51205-w
https://doi.org/10.1038/s41598-019-51205-w